CDEK
← All organizations

Medicines Development for Global Health

For profitContributed to NMEWebsite ↗

Also known as: MDGH | Medicines Development for Global Health | Medicines Development Limited

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2010

First marketed drug

Jun 13, 2018

First NDA

Jun 13, 2018

Last known activity

Mar 31, 2026

Timeline

2000s

  1. Jul 1, 2005

    Medicines Development for Global Health— Founded

2010s

  1. Jun 13, 2018

    moxidectin— NDA Organization

  2. Jun 13, 2018

    moxidectin— NDA Secondary Org

Drugs by trial phase (9 distinct, 10 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (10)

Details

Founded
Melbourne, AU Jul 1, 2005
First NDA
Jun 13, 2018
Last known activity
Mar 31, 2026

Designations held

  • Orphan drug
  • Priority review